BCHE and Alzheimer disease: The key therapeutic strategy for managing AD involves the inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE), enzymes responsible for the hydrolysis of acetylcholine, leading to improved cholinergic transmission [2,3].